Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Haematologica|December 18, 2009
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Jeroen J W M Janssen, Bronno van der Holt, et al.Blood|July 29, 2015
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international studyHiroto Inaba, Yinmei Zhou, Oussama Abla, et al.Blood|January 4, 2008
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Bronno van der Holt, Gregor E G Verhoef, et al.Cancer Cell|April 13, 2011
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemiaIrene Homminga, Rob Pieters, Anton W Langerak, et al.Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupStefan Gröschel, Richard F Schlenk, Jan Engelmann, et al.European Journal of Human Genetics : EJHG|July 21, 2016
Copy number variations in 375 patients with oesophageal atresia and/or tracheoesophageal fistulaErwin Brosens, Florian Marsch, Elisabeth M de Jong, et al.Haematologica|January 21, 2014
t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patientsJulie Damgaard Sandahl, Eva A Coenen, Erik Forestier, et al.Leukemia|April 26, 2022
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trialEdoardo Pennesi, Naomi Michels, Erica Brivio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemiaSanne Lugthart, Stefan Gröschel, H Berna Beverloo, et al.Pageof 10